CVE-2026-15415AWS HealthOmics is a HIPAA-eligible service that fully manages the compute, storage, and workflow engine infrastructure required to run bioinformatics analyses at scale for clinical diagnostics, drug…

AWS HealthOmics is a HIPAA-eligible service that fully manages the compute, storage, and workflow engine infrastructure required to run bioinformatics analyses at scale for clinical diagnostics, drug discovery, and agricultural research. Improper limitation of a pathname to a restricted directory in the linting tools of the AWS HealthOmics MCP Server (aws-healthomics-mcp-server) before version 0.0.36 might allow an actor who can influence the MCP agent to write an actor-controlled content to arbitrary locations outside the intended workflow bundle directory, via directory traversal sequences in the workflow_files input. To remediate this issue, users should upgrade to version 0.0.36 or later.

CVSS

5.5 MEDIUM (v3.1, NVD)CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:N/I:H/A:N

Weakness (CWE)

CWE-23

Known exploited

Not in CISA's KEV catalog

EPSS (exploitation in the next 30 days)

Not loaded for this CVE

Assigned by

Not given

NVD analysis

Awaiting Analysis

Record last updated

Jul 20, 2026

First seen by InfoSec Signals

Oct 9, 2026

The CVE record on cve.org · NVD's entry

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.